{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:54:49Z","timestamp":1794448489623,"version":"4.9.1"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01424-6","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:46:09Z","timestamp":1780566369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exercise and smoking: health rivals revealing shared protective mechanisms in Parkinson\u2019s?"],"prefix":"10.1038","volume":"12","author":[{"given":"Jules M.","family":"Janssen Daalen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schootemeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Oosterhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilke M.","family":"Ripping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen N.","family":"Gomperts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Schwarzschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"1424_CR1","doi-asserted-by":"publisher","first-page":"e182421","DOI":"10.1001\/jamanetworkopen.2018.2421","volume":"1","author":"X Fang","year":"2018","unstructured":"Fang, X. et al. Association of levels of physical activity with risk of Parkinson disease: a systematic review and meta-analysis. JAMA Netw. Open 1, e182421 (2018).","journal-title":"JAMA Netw. Open"},{"key":"1424_CR2","doi-asserted-by":"publisher","first-page":"e0151841","DOI":"10.1371\/journal.pone.0151841","volume":"11","author":"CB Breckenridge","year":"2016","unstructured":"Breckenridge, C. B., Berry, C., Chang, E. T., Sielken, R. L. Jr & Mandel, J. S. Association between Parkinson\u2019s disease and cigarette smoking, rural living, well-water consumption, farming and pesticide use: systematic review and meta-analysis. PLoS ONE 11, e0151841 (2016).","journal-title":"PLoS ONE"},{"key":"1424_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/oxfordjournals.aje.a120874","volume":"88","author":"MD Nefzger","year":"1968","unstructured":"Nefzger, M. D., Quadfasel, F. A. & Karl, V. C. A retrospective study of smoking in Parkinson\u2019s disease. Am. J. Epidemiol. 88, 149\u2013158 (1968).","journal-title":"Am. J. Epidemiol."},{"key":"1424_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/oxfordjournals.aje.a121289","volume":"94","author":"II Kessler","year":"1971","unstructured":"Kessler, I. I. & Diamond, E. L. Epidemiologic studies of Parkinson\u2019s disease. I. Smoking and Parkinson\u2019s disease: a survey and explanatory hypothesis. Am. J. Epidemiol. 94, 16\u201325 (1971).","journal-title":"Am. J. Epidemiol."},{"key":"1424_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1212\/WNL.30.8.839","volume":"30","author":"RJ Baumann","year":"1980","unstructured":"Baumann, R. J., Jameson, H. D., McKean, H. E., Haack, D. G. & Weisberg, L. M. Cigarette smoking and Parkinson disease: 1. Comparison of cases with matched neighbors. Neurology 30, 839\u2013843 (1980).","journal-title":"Neurology"},{"key":"1424_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1600-0404.1980.tb03043.x","volume":"62","author":"RJ Marttila","year":"1980","unstructured":"Marttila, R. J. & Rinne, U. K. Smoking and Parkinson\u2019s disease. Acta Neurol. Scand. 62, 322\u2013325 (1980).","journal-title":"Acta Neurol. Scand."},{"key":"1424_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jnnp.45.7.577","volume":"45","author":"RB Godwin-Austen","year":"1982","unstructured":"Godwin-Austen, R. B., Lee, P. N., Marmot, M. G. & Stern, G. M. Smoking and Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 45, 577\u2013581 (1982).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1424_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1212\/WNL.0000000000200787","volume":"99","author":"JM Janssen Daalen","year":"2022","unstructured":"Janssen Daalen, J. M., Schootemeijer, S., Richard, E., Darweesh, S. K. L. & Bloem, B. R. Lifestyle Interventions for the prevention of Parkinson disease: a recipe for action. Neurology 99, 42\u201351 (2022).","journal-title":"Neurology"},{"key":"1424_CR9","unstructured":"Organization, W.H. WHO Report on the Global Tobacco Epidemic, 2023: Protect People from Tobacco Smoke. (2023)."},{"key":"1424_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1212\/WNL.58.4.581","volume":"58","author":"CM Tanner","year":"2002","unstructured":"Tanner, C. M. et al. Smoking and Parkinson\u2019s disease in twins. Neurology 58, 581\u2013588 (2002).","journal-title":"Neurology"},{"key":"1424_CR11","first-page":"912","volume":"48","author":"V Gallo","year":"2019","unstructured":"Gallo, V. et al. Exploring causality of the association between smoking and Parkinson\u2019s disease. Int. J. Epidemiol. 48, 912\u2013925 (2019).","journal-title":"Int. J. Epidemiol."},{"key":"1424_CR12","doi-asserted-by":"publisher","first-page":"e2132","DOI":"10.1212\/WNL.0000000000009437","volume":"94","author":"B Mappin-Kasirer","year":"2020","unstructured":"Mappin-Kasirer, B. et al. Tobacco smoking and the risk of Parkinson disease: a 65-year follow-up of 30,000 male British doctors. Neurology 94, e2132\u2013e2138 (2020).","journal-title":"Neurology"},{"key":"1424_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/JPD-212851","volume":"12","author":"C Domenighetti","year":"2022","unstructured":"Domenighetti, C. et al. Mendelian randomisation study of smoking, alcohol, and coffee drinking in relation to Parkinson\u2019s disease. J. Parkinsons Dis. 12, 267\u2013282 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1424_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93105-y","volume":"11","author":"C Dominguez-Baleon","year":"2021","unstructured":"Dominguez-Baleon, C., Ong, J. S., Scherzer, C. R., Renteria, M. E. & Dong, X. Understanding the effect of smoking and drinking behavior on Parkinson\u2019s disease risk: a Mendelian randomization study. Sci. Rep. 11, 13980 (2021).","journal-title":"Sci. Rep."},{"key":"1424_CR15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3233\/JPD-223188","volume":"12","author":"BR Ritz","year":"2022","unstructured":"Ritz, B. R. & Kusters, C. D. J. The promise of mendelian randomization in Parkinson\u2019s disease: has the smoke cleared yet for smoking and Parkinson\u2019s disease risk? J. Parkinsons Dis. 12, 807\u2013812 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1424_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175778","volume":"950","author":"HK Huang","year":"2023","unstructured":"Huang, H. K. et al. Nicotine activates HIF-1alpha and regulates acid extruders through the nicotinic acetylcholine receptor to promote the Warburg effect in non-small cell lung cancer cells. Eur. J. Pharm. 950, 175778 (2023).","journal-title":"Eur. J. Pharm."},{"key":"1424_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep34424","volume":"6","author":"H Daijo","year":"2016","unstructured":"Daijo, H. et al. Cigarette smoke reversibly activates hypoxia-inducible factor 1 in a reactive oxygen species-dependent manner. Sci. Rep. 6, 34424 (2016).","journal-title":"Sci. Rep."},{"key":"1424_CR18","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1021\/tx300145n","volume":"25","author":"T Muller","year":"2012","unstructured":"Muller, T. & Hengstermann, A. Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease. Chem. Res Toxicol. 25, 1805\u20131824 (2012).","journal-title":"Chem. Res Toxicol."},{"key":"1424_CR19","doi-asserted-by":"publisher","first-page":"C62","DOI":"10.1152\/ajpcell.00162.2017","volume":"314","author":"AT Erlich","year":"2018","unstructured":"Erlich, A. T., Brownlee, D. M., Beyfuss, K. & Hood, D. A. Exercise induces TFEB expression and activity in skeletal muscle in a PGC-1alpha-dependent manner. Am. J. Physiol. Cell Physiol. 314, C62\u2013C72 (2018).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1424_CR20","doi-asserted-by":"publisher","first-page":"E513","DOI":"10.1152\/ajpendo.00059.2019","volume":"317","author":"JF Halling","year":"2019","unstructured":"Halling, J. F. et al. PGC-1alpha regulates mitochondrial properties beyond biogenesis with aging and exercise training. Am. J. Physiol. Endocrinol. Metab. 317, E513\u2013E525 (2019).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1424_CR21","doi-asserted-by":"publisher","first-page":"E145","DOI":"10.1152\/ajpendo.00755.2009","volume":"299","author":"VA Lira","year":"2010","unstructured":"Lira, V. A., Benton, C. R., Yan, Z. & Bonen, A. PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 299, E145\u2013161 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1424_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1460-9568.2007.05636.x","volume":"26","author":"HJ Park","year":"2007","unstructured":"Park, H. J. et al. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur. J. Neurosci. 26, 79\u201389 (2007).","journal-title":"Eur. J. Neurosci."},{"key":"1424_CR23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1096\/fj.04-2304fje","volume":"19","author":"H Ameln","year":"2005","unstructured":"Ameln, H. et al. Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. Faseb J. 19, 1009\u20131011 (2005).","journal-title":"Faseb J."},{"key":"1424_CR24","doi-asserted-by":"publisher","first-page":"C272","DOI":"10.1152\/ajpcell.00297.2025","volume":"329","author":"J Aragon-Vela","year":"2025","unstructured":"Aragon-Vela, J. & Casuso, R. A. Effect of hypoxia-inducible factor 1 on vascular endothelial growth factor expression in exercised human skeletal muscle: a systematic review and meta-analysis. Am. J. Physiol. Cell Physiol. 329, C272\u2013C282 (2025).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1424_CR25","doi-asserted-by":"publisher","first-page":"808","DOI":"10.5551\/jat.42432","volume":"25","author":"AM Fratta Pasini","year":"2018","unstructured":"Fratta Pasini, A. M. et al. Physical exercise reduces cytotoxicity and up-regulates Nrf2 and UPR expression in circulating cells of peripheral artery disease patients: an hypoxic adaptation? J. Atheroscler. Thromb. 25, 808\u2013820 (2018).","journal-title":"J. Atheroscler. Thromb."},{"key":"1424_CR26","doi-asserted-by":"crossref","unstructured":"Rose, K.N. et al. Neuroprotection of low dose carbon monoxide in Parkinson's disease models commensurate with the reduced risk ofParkinson's among smokers. NPJ Parkinsons Dis. 10, 152 (2024).","DOI":"10.1038\/s41531-024-00763-6"},{"key":"1424_CR27","doi-asserted-by":"publisher","first-page":"EVIDoa2200311","DOI":"10.1056\/EVIDoa2200311","volume":"2","author":"WH Oertel","year":"2023","unstructured":"Oertel, W. H. et al. Transdermal nicotine treatment and progression of early Parkinson\u2019s disease. NEJM Evid. 2, EVIDoa2200311 (2023).","journal-title":"NEJM Evid."},{"key":"1424_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02770-7","volume":"22","author":"JM Janssen Daalen","year":"2022","unstructured":"Janssen Daalen, J. M. et al. Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson\u2019s disease: study rationale and protocol. BMC Neurol. 22, 262 (2022).","journal-title":"BMC Neurol."},{"key":"1424_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mds.29688","volume":"39","author":"JM Janssen Daalen","year":"2024","unstructured":"Janssen Daalen, J. M. et al. The hypoxia response pathway: a potential intervention target in Parkinson\u2019s disease? Mov. Disord. 39, 273\u2013293 (2024).","journal-title":"Mov. Disord."},{"key":"1424_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1223310","volume":"15","author":"SY Jung","year":"2023","unstructured":"Jung, S. Y. et al. Changes in smoking, alcohol consumption, and the risk of Parkinson\u2019s disease. Front. Aging Neurosci. 15, 1223310 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"1424_CR31","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/archneur.64.7.990","volume":"64","author":"B Ritz","year":"2007","unstructured":"Ritz, B. et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch. Neurol. 64, 990\u2013997 (2007).","journal-title":"Arch. Neurol."},{"key":"1424_CR32","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3233\/JPD-223148","volume":"12","author":"J Nie","year":"2022","unstructured":"Nie, J. et al. Independent and Joint Associations of Tea Consumption and smoking with Parkinson\u2019s Disease risk in Chinese adults. J. Parkinsons Dis. 12, 1693\u20131702 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1424_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3988\/jcn.2020.16.3.455","volume":"16","author":"R Kim","year":"2020","unstructured":"Kim, R., Yoo, D., Jung, Y. J., Han, K. & Lee, J. Y. Smoking cessation, weight change, and risk of parkinson\u2019s disease: analysis of National Cohort Data. J. Clin. Neurol. 16, 455\u2013460 (2020).","journal-title":"J. Clin. Neurol."},{"key":"1424_CR34","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JPD-202522","volume":"11","author":"J Sieurin","year":"2021","unstructured":"Sieurin, J., Zhan, Y., Pedersen, N. L. & Wirdefeldt, K. Neuroticism, smoking, and the risk of Parkinson\u2019s Disease. J. Parkinsons Dis. 11, 1325\u20131334 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"1424_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1515\/reveh-2020-0053","volume":"36","author":"W Liu","year":"2021","unstructured":"Liu, W., Wang, B., Xiao, Y., Wang, D. & Chen, W. Secondhand smoking and neurological disease: a meta-analysis of cohort studies. Rev. Environ. Health 36, 271\u2013277 (2021).","journal-title":"Rev. Environ. Health"},{"key":"1424_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.puhe.2019.09.020","volume":"179","author":"C Han","year":"2020","unstructured":"Han, C., Lu, Y., Cheng, H., Wang, C. & Chan, P. The impact of long-term exposure to ambient air pollution and second-hand smoke on the onset of Parkinson disease: a review and meta-analysis. Public Health 179, 100\u2013110 (2020).","journal-title":"Public Health"},{"key":"1424_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.parkreldis.2017.10.001","volume":"45","author":"NM Gatto","year":"2017","unstructured":"Gatto, N. M. et al. Passive smoking and Parkinson\u2019s disease in California Teachers. Parkinsonism Relat. Disord. 45, 44\u201349 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1424_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.parkreldis.2017.09.022","volume":"45","author":"AF Gigante","year":"2017","unstructured":"Gigante, A. F., Martino, T., Iliceto, G. & Defazio, G. Smoking and age-at-onset of both motor and non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 45, 94\u201396 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1424_CR39","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1007\/s00415-022-11041-x","volume":"269","author":"C Gabbert","year":"2022","unstructured":"Gabbert, C. et al. Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson\u2019s disease. J. Neurol. 269, 4195\u20134203 (2022).","journal-title":"J. Neurol."},{"key":"1424_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2022.03.005","volume":"97","author":"I Rosas","year":"2022","unstructured":"Rosas, I. et al. Smoking is associated with age at disease onset in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 97, 79\u201383 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1424_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/ane.12537","volume":"134","author":"AF Gigante","year":"2016","unstructured":"Gigante, A. F. et al. Smoking in patients with Parkinson\u2019s disease: preliminary striatal DaT-SPECT findings. Acta Neurol. Scand. 134, 265\u2013270 (2016).","journal-title":"Acta Neurol. Scand."},{"key":"1424_CR42","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3233\/JPD-150639","volume":"5","author":"M Moccia","year":"2015","unstructured":"Moccia, M. et al. Non-motor correlates of smoking habits in de novo Parkinson\u2019s disease. J. Parkinsons Dis. 5, 913\u2013924 (2015).","journal-title":"J. Parkinsons Dis."},{"key":"1424_CR43","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/13607863.2015.1090393","volume":"21","author":"M Doiron","year":"2017","unstructured":"Doiron, M., Dupre, N., Langlois, M., Provencher, P. & Simard, M. Smoking history is associated to cognitive impairment in Parkinson\u2019s disease. Aging Ment. Health 21, 322\u2013326 (2017).","journal-title":"Aging Ment. Health"},{"key":"1424_CR44","doi-asserted-by":"publisher","first-page":"117534","DOI":"10.1016\/j.jns.2021.117534","volume":"427","author":"S Neshige","year":"2021","unstructured":"Neshige, S., Ohshita, T., Neshige, R. & Maruyama, H. Influence of current and previous smoking on current phenotype in Parkinson\u2019s disease. J. Neurol. Sci. 427, 117534 (2021).","journal-title":"J. Neurol. Sci."},{"key":"1424_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41531-023-00486-0","volume":"9","author":"SY Yoon","year":"2023","unstructured":"Yoon, S. Y. et al. Association between smoking and all-cause mortality in Parkinson\u2019s disease. NPJ Parkinsons Dis. 9, 59 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1424_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/brain\/awu323","volume":"138","author":"F Yang","year":"2015","unstructured":"Yang, F. et al. Physical activity and risk of Parkinson\u2019s disease in the Swedish National March Cohort. Brain 138, 269\u2013275 (2015).","journal-title":"Brain"},{"key":"1424_CR47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrneurol.2017.128","volume":"13","author":"MK Mak","year":"2017","unstructured":"Mak, M. K., Wong-Yu, I. S., Shen, X. & Chung, C. L. Long-term effects of exercise and physical therapy in people with Parkinson disease. Nat. Rev. Neurol. 13, 689\u2013703 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"1424_CR48","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000013218","volume":"98","author":"K Tsukita","year":"2022","unstructured":"Tsukita, K., Sakamaki-Tsukita, H. & Takahashi, R. Long-term effect of regular physical activity and exercise habits in patients with early Parkinson disease. Neurology 98, e859\u2013e871 (2022).","journal-title":"Neurology"},{"key":"1424_CR49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/jamaneurol.2017.3517","volume":"75","author":"M Schenkman","year":"2018","unstructured":"Schenkman, M. et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol. 75, 219\u2013226 (2018).","journal-title":"JAMA Neurol."},{"key":"1424_CR50","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","volume":"18","author":"NM van der Kolk","year":"2019","unstructured":"van der Kolk, N. M. et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson\u2019s disease: a double-blind, randomised controlled trial. Lancet Neurol. 18, 998\u20131008 (2019).","journal-title":"Lancet Neurol."},{"key":"1424_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ana.26291","volume":"91","author":"ME Johansson","year":"2022","unstructured":"Johansson, M. E. et al. Aerobic exercise alters brain function and structure in Parkinson\u2019s disease: a randomized controlled trial. Ann. Neurol. 91, 203\u2013216 (2022).","journal-title":"Ann. Neurol."},{"key":"1424_CR52","doi-asserted-by":"crossref","unstructured":"Hong, C.T., Chan, L. & Bai, C.H. The effect of caffeine on the risk and progression of Parkinson\u2019s disease: a meta-analysis. Nutrients 12, 1860 (2020).","DOI":"10.3390\/nu12061860"},{"key":"1424_CR53","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"1424_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1212\/WNL.41.5_Suppl_2.73","volume":"41","author":"GW Paulson","year":"1991","unstructured":"Paulson, G. W. & Dadmehr, N. Is there a premorbid personality typical for Parkinson\u2019s disease? Neurology 41, 73\u201376 (1991).","journal-title":"Neurology"},{"key":"1424_CR55","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature11432","volume":"489","author":"JA Mattison","year":"2012","unstructured":"Mattison, J. A. et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 489, 318\u2013321 (2012).","journal-title":"Nature"},{"key":"1424_CR56","doi-asserted-by":"publisher","first-page":"18171","DOI":"10.1073\/pnas.0405831102","volume":"101","author":"N Maswood","year":"2004","unstructured":"Maswood, N. et al. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson\u2019s disease. Proc. Natl. Acad. Sci. USA. 101, 18171\u201318176 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1424_CR57","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1753-4887.2011.00413.x","volume":"69","author":"JM Sheard","year":"2011","unstructured":"Sheard, J. M., Ash, S., Silburn, P. A. & Kerr, G. K. Prevalence of malnutrition in Parkinson\u2019s disease: a systematic review. Nutr. Rev. 69, 520\u2013532 (2011).","journal-title":"Nutr. Rev."},{"key":"1424_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2019.01.031","volume":"62","author":"YH Chuang","year":"2019","unstructured":"Chuang, Y. H. et al. Genetic variants in nicotinic receptors and smoking cessation in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 62, 57\u201361 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1424_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41746-024-01135-3","volume":"7","author":"F Lin","year":"2024","unstructured":"Lin, F. et al. Association of physical activity pattern and risk of Parkinson\u2019s disease. NPJ Digit Med. 7, 137 (2024).","journal-title":"NPJ Digit Med."},{"key":"1424_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-023-00462-8","volume":"9","author":"K Han","year":"2023","unstructured":"Han, K., Kim, B., Lee, S. H. & Kim, M. K. A nationwide cohort study on diabetes severity and risk of Parkinson disease. NPJ Parkinsons Dis. 9, 11 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1424_CR61","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2337\/dc06-2011","volume":"30","author":"G Hu","year":"2007","unstructured":"Hu, G., Jousilahti, P., Bidel, S., Antikainen, R. & Tuomilehto, J. Type 2 diabetes and the risk of Parkinson\u2019s disease. Diab. Care 30, 842\u2013847 (2007).","journal-title":"Diab. Care"},{"key":"1424_CR62","doi-asserted-by":"crossref","unstructured":"Rose, K. N., Schwarzschild, M. A. & Gomperts, S. N. Clearing the Smoke: What Protects Smokers from Parkinson's Disease? Mov Disord. 39, 267\u2013272 (2024).","DOI":"10.1002\/mds.29707"},{"key":"1424_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuro.2024.12.003","volume":"106","author":"SW Hong","year":"2025","unstructured":"Hong, S. W., Page, R. & Truman, P. Smoking, coffee intake, and Parkinson\u2019s disease: potential protective mechanisms and components. Neurotoxicology 106, 48\u201363 (2025).","journal-title":"Neurotoxicology"},{"key":"1424_CR64","doi-asserted-by":"publisher","first-page":"885489","DOI":"10.3389\/fnins.2022.885489","volume":"16","author":"SW Hong","year":"2022","unstructured":"Hong, S. W., Teesdale-Spittle, P., Page, R., Ellenbroek, B. & Truman, P. Biologically active compounds present in tobacco smoke: potential interactions between smoking and mental health. Front. Neurosci. 16, 885489 (2022).","journal-title":"Front. Neurosci."},{"key":"1424_CR65","first-page":"872","volume":"46","author":"F Yang","year":"2017","unstructured":"Yang, F. et al. Moist smokeless tobacco (Snus) use and risk of Parkinson\u2019s disease. Int. J. Epidemiol. 46, 872\u2013880 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"1424_CR66","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/mds.20587","volume":"20","author":"EJ O\u2019Reilly","year":"2005","unstructured":"O\u2019Reilly, E. J. et al. Smokeless tobacco use and the risk of Parkinson\u2019s disease mortality. Mov. Disord. 20, 1383\u20131384 (2005).","journal-title":"Mov. Disord."},{"key":"1424_CR67","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221092566","volume":"15","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Association between cigarette smoking and Parkinson\u2019s disease: a neuroimaging study. Ther. Adv. Neurol. Disord. 15, 17562864221092566 (2022).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"1424_CR68","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1016\/j.neuron.2022.07.011","volume":"110","author":"PF Kramer","year":"2022","unstructured":"Kramer, P. F. et al. Synaptic-like axo-axonal transmission from striatal cholinergic interneurons onto dopaminergic fibers. Neuron 110, 2949\u20132960 e2944 (2022).","journal-title":"Neuron"},{"key":"1424_CR69","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1073\/pnas.0609611104","volume":"104","author":"BY Chin","year":"2007","unstructured":"Chin, B. Y. et al. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc. Natl. Acad. Sci. USA. 104, 5109\u20135114 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1424_CR70","doi-asserted-by":"publisher","first-page":"32116","DOI":"10.1074\/jbc.M110.131284","volume":"285","author":"YK Choi","year":"2010","unstructured":"Choi, Y. K. et al. Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein. J. Biol. Chem. 285, 32116\u201332125 (2010).","journal-title":"J. Biol. Chem."},{"key":"1424_CR71","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41420-023-01695-5","volume":"9","author":"Y Henning","year":"2023","unstructured":"Henning, Y. et al. Cigarette smoke causes a bioenergetic crisis in RPE cells involving the downregulation of HIF-1alpha under normoxia. Cell Death Discov. 9, 398 (2023).","journal-title":"Cell Death Discov."},{"key":"1424_CR72","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/ana.25082","volume":"82","author":"Y Lee","year":"2017","unstructured":"Lee, Y. et al. Does smoking impact dopamine neuronal loss in de novo Parkinson disease? Ann. Neurol. 82, 850\u2013854 (2017).","journal-title":"Ann. Neurol."},{"key":"1424_CR73","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/379733a0","volume":"379","author":"JS Fowler","year":"1996","unstructured":"Fowler, J. S. et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379, 733\u2013736 (1996).","journal-title":"Nature"},{"key":"1424_CR74","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuroscience.2016.02.035","volume":"322","author":"K Xu","year":"2016","unstructured":"Xu, K. et al. Neuroprotection by caffeine in the MPTP model of parkinson\u2019s disease and its dependence on adenosine A2A receptors. Neuroscience 322, 129\u2013137 (2016).","journal-title":"Neuroscience"},{"key":"1424_CR75","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/03602530903286476","volume":"42","author":"SF Zhou","year":"2010","unstructured":"Zhou, S. F., Wang, B., Yang, L. P. & Liu, J. P. Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab. Rev. 42, 268\u2013354 (2010).","journal-title":"Drug Metab. Rev."},{"key":"1424_CR76","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0140-6736(97)07541-7","volume":"351","author":"A Ott","year":"1998","unstructured":"Ott, A. et al. Smoking and risk of dementia and Alzheimer\u2019s disease in a population-based cohort study: the Rotterdam Study. Lancet 351, 1840\u20131843 (1998).","journal-title":"Lancet"},{"key":"1424_CR77","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/j.jalz.2014.04.009","volume":"10","author":"TC Durazzo","year":"2014","unstructured":"Durazzo, T. C., Mattsson, N. & Weiner, M. W. Alzheimer\u2019s Disease Neuroimaging, I. Smoking and increased Alzheimer\u2019s disease risk: a review of potential mechanisms. Alzheimers Dement. 10, S122\u2013145 (2014).","journal-title":"Alzheimers Dement."},{"key":"1424_CR78","doi-asserted-by":"publisher","first-page":"107133","DOI":"10.1016\/j.parkreldis.2024.107133","volume":"128","author":"AE Goodheart","year":"2024","unstructured":"Goodheart, A. E. & Gomperts, S. N. The association between cigarette smoking and dementia with Lewy bodies. Parkinsonism Relat. Disord. 128, 107133 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1424_CR79","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"1424_CR80","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"1424_CR81","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbi.2010.09.006","volume":"25","author":"SY Wu","year":"2011","unstructured":"Wu, S. Y. et al. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway. Brain Behav. Immun. 25, 135\u2013146 (2011).","journal-title":"Brain Behav. Immun."},{"key":"1424_CR82","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1523\/JNEUROSCI.2273-21.2022","volume":"42","author":"G Bastioli","year":"2022","unstructured":"Bastioli, G. et al. Voluntary exercise boosts striatal dopamine release: evidence for the necessary and sufficient role of BDNF. J. Neurosci. 42, 4725\u20134736 (2022).","journal-title":"J. Neurosci."},{"key":"1424_CR83","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh1403","volume":"9","author":"G Marino","year":"2023","unstructured":"Marino, G. et al. Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson\u2019s disease restoring striatal synaptic plasticity. Sci. Adv. 9, eadh1403 (2023).","journal-title":"Sci. Adv."},{"key":"1424_CR84","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.lfs.2018.08.045","volume":"209","author":"Y Jang","year":"2018","unstructured":"Jang, Y. et al. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD. Life Sci. 209, 455\u2013465 (2018).","journal-title":"Life Sci."},{"key":"1424_CR85","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s12640-019-0004-x","volume":"35","author":"Z Rezaee","year":"2019","unstructured":"Rezaee, Z., Marandi, S. M., Alaei, H., Esfarjani, F. & Feyzollahzadeh, S. Effects of preventive treadmill exercise on the recovery of metabolic and mitochondrial factors in the 6-hydroxydopamine rat model of Parkinson\u2019s disease. Neurotox. Res. 35, 908\u2013917 (2019).","journal-title":"Neurotox. Res."},{"key":"1424_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146301","volume":"1720","author":"JH Lai","year":"2019","unstructured":"Lai, J. H. et al. Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson\u2019s disease. Brain Res. 1720, 146301 (2019).","journal-title":"Brain Res."},{"key":"1424_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112607","volume":"387","author":"AFF Ferreira","year":"2020","unstructured":"Ferreira, A. F. F. et al. Physical exercise protects against mitochondria alterations in the 6-hidroxydopamine rat model of Parkinson\u2019s disease. Behav. Brain Res. 387, 112607 (2020).","journal-title":"Behav. Brain Res."},{"key":"1424_CR88","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/WNR.0000000000001239","volume":"30","author":"MR Halliday","year":"2019","unstructured":"Halliday, M. R., Abeydeera, D., Lundquist, A. J., Petzinger, G. M. & Jakowec, M. W. Intensive treadmill exercise increases expression of hypoxia-inducible factor 1alpha and its downstream transcript targets: a potential role in neuroplasticity. Neuroreport 30, 619\u2013627 (2019).","journal-title":"Neuroreport"},{"key":"1424_CR89","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(25)00184-9","volume":"405","author":"AR Tari","year":"2025","unstructured":"Tari, A. R., Walker, T. L., Huuha, A. M., Sando, S. B. & Wisloff, U. Neuroprotective mechanisms of exercise and the importance of fitness for healthy brain ageing. Lancet 405, 1093\u20131118 (2025).","journal-title":"Lancet"},{"key":"1424_CR90","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3233\/JPD-223216","volume":"12","author":"SKL Darweesh","year":"2022","unstructured":"Darweesh, S. K. L. et al. Inhibition of neuroinflammation may mediate the disease-modifying effects of exercise: implications for Parkinson\u2019s disease. J. Parkinsons Dis. 12, 1419\u20131422 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1424_CR91","first-page":"1","volume":"51","author":"JW Lee","year":"2019","unstructured":"Lee, J. W., Ko, J., Ju, C. & Eltzschig, H. K. Hypoxia signaling in human diseases and therapeutic targets. Exp. Mol. Med. 51, 1\u201313 (2019).","journal-title":"Exp. Mol. Med."},{"key":"1424_CR92","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuroscience.2015.03.015","volume":"295","author":"M Smeyne","year":"2015","unstructured":"Smeyne, M., Sladen, P., Jiao, Y., Dragatsis, I. & Smeyne, R. J. HIF1alpha is necessary for exercise-induced neuroprotection while HIF2alpha is needed for dopaminergic neuron survival in the substantia nigra pars compacta. Neuroscience 295, 23\u201338 (2015).","journal-title":"Neuroscience"},{"key":"1424_CR93","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00421-022-04909-3","volume":"122","author":"RC Nava","year":"2022","unstructured":"Nava, R. C. et al. Repeated sprint exercise in hypoxia stimulates HIF-1-dependent gene expression in skeletal muscle. Eur. J. Appl. Physiol. 122, 1097\u20131107 (2022).","journal-title":"Eur. J. Appl. Physiol."},{"key":"1424_CR94","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1113\/EP085318","volume":"101","author":"ME Lindholm","year":"2016","unstructured":"Lindholm, M. E. & Rundqvist, H. Skeletal muscle hypoxia-inducible factor-1 and exercise. Exp. Physiol. 101, 28\u201332 (2016).","journal-title":"Exp. Physiol."},{"key":"1424_CR95","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1096\/fj.02-0172fje","volume":"17","author":"SE Michaud","year":"2003","unstructured":"Michaud, S. E., Menard, C., Guy, L. G., Gennaro, G. & Rivard, A. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1alpha\/VEGF pathway. Faseb J. 17, 1150\u20131152 (2003).","journal-title":"Faseb J."},{"key":"1424_CR96","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1017\/jsc.2020.15","volume":"15","author":"I Pallardo-Fern\u00e1ndez","year":"2020","unstructured":"Pallardo-Fern\u00e1ndez, I., Iglesias, V., Rodr\u00edguez-Rivera, C., Gonz\u00e1lez-Mart\u00edn, C. & Alguacil, L. F. Salivary clusterin as a biomarker of tobacco consumption in nicotine addicts undergoing smoking cessation therapy. J. Smok. Cessat. 15, 171\u2013174 (2020).","journal-title":"J. Smok. Cessat."},{"key":"1424_CR97","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1073\/pnas.0813361106","volume":"106","author":"PC Chen","year":"2009","unstructured":"Chen, P. C. et al. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson\u2019s disease: critical role for the astrocyte. Proc. Natl. Acad. Sci. USA 106, 2933\u20132938 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1424_CR98","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.freeradbiomed.2021.05.039","volume":"172","author":"EL Ostrom","year":"2021","unstructured":"Ostrom, E. L., Valencia, A. P., Marcinek, D. J. & Traustadottir, T. High intensity muscle stimulation activates a systemic Nrf2-mediated redox stress response. Free Radic. Biol. Med. 172, 82\u201389 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"1424_CR99","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.freeradbiomed.2011.10.440","volume":"52","author":"VR Muthusamy","year":"2012","unstructured":"Muthusamy, V. R. et al. Acute exercise stress activates Nrf2\/ARE signaling and promotes antioxidant mechanisms in the myocardium. Free Radic. Biol. Med 52, 366\u2013376 (2012).","journal-title":"Free Radic. Biol. Med"},{"key":"1424_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12993-020-00171-9","volume":"16","author":"DM Monir","year":"2020","unstructured":"Monir, D. M., Mahmoud, M. E., Ahmed, O. G., Rehan, I. F. & Abdelrahman, A. Forced exercise activates the NrF2 pathway in the striatum and ameliorates motor and behavioral manifestations of Parkinson\u2019s disease in rotenone-treated rats. Behav. Brain Funct. 16, 9 (2020).","journal-title":"Behav. Brain Funct."},{"key":"1424_CR101","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3109\/10715762.2015.1066784","volume":"49","author":"T Li","year":"2015","unstructured":"Li, T. et al. Effects of different exercise durations on Keap1-Nrf2-ARE pathway activation in mouse skeletal muscle. Free Radic. Res. 49, 1269\u20131274 (2015).","journal-title":"Free Radic. Res."},{"key":"1424_CR102","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2016.04.024","volume":"96","author":"AJ Done","year":"2016","unstructured":"Done, A. J., Gage, M. J., Nieto, N. C. & Traustadottir, T. Exercise-induced Nrf2-signaling is impaired in aging. Free Radic. Biol. Med. 96, 130\u2013138 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"1424_CR103","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11064-015-1709-8","volume":"41","author":"AS Aguiar Jr.","year":"2016","unstructured":"Aguiar, A. S. Jr. et al. Moderate-intensity physical exercise protects against experimental 6-hydroxydopamine-induced hemiparkinsonism through Nrf2-antioxidant response element pathway. Neurochem. Res. 41, 64\u201372 (2016).","journal-title":"Neurochem. Res."},{"key":"1424_CR104","doi-asserted-by":"publisher","first-page":"e8225","DOI":"10.1371\/journal.pone.0008225","volume":"4","author":"U Garbin","year":"2009","unstructured":"Garbin, U. et al. Cigarette smoking blocks the protective expression of Nrf2\/ARE pathway in peripheral mononuclear cells of young heavy smokers favouring inflammation. PLoS ONE 4, e8225 (2009).","journal-title":"PLoS ONE"},{"key":"1424_CR105","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10715760400022327","volume":"39","author":"D Thompson","year":"2005","unstructured":"Thompson, D. et al. Exercise-induced expression of heme oxygenase-1 in human lymphocytes. Free Radic. Res. 39, 63\u201369 (2005).","journal-title":"Free Radic. Res."},{"key":"1424_CR106","doi-asserted-by":"publisher","first-page":"L624","DOI":"10.1152\/ajplung.90215.2008","volume":"295","author":"CJ Baglole","year":"2008","unstructured":"Baglole, C. J., Sime, P. J. & Phipps, R. P. Cigarette smoke-induced expression of heme oxygenase-1 in human lung fibroblasts is regulated by intracellular glutathione. Am. J. Physiol. Lung Cell Mol. Physiol. 295, L624\u2013636 (2008).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"1424_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-104","volume":"8","author":"RH Shih","year":"2011","unstructured":"Shih, R. H., Cheng, S. E., Hsiao, L. D., Kou, Y. R. & Yang, C. M. Cigarette smoke extract upregulates heme oxygenase-1 via PKC\/NADPH oxidase\/ROS\/PDGFR\/PI3K\/Akt pathway in mouse brain endothelial cells. J. Neuroinflamm. 8, 104 (2011).","journal-title":"J. Neuroinflamm."},{"key":"1424_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109018","volume":"35","author":"RW Alves de Souza","year":"2021","unstructured":"Alves de Souza, R. W. et al. Skeletal muscle heme oxygenase-1 activity regulates aerobic capacity. Cell Rep. 35, 109018 (2021).","journal-title":"Cell Rep."},{"key":"1424_CR109","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","volume":"127","author":"J St-Pierre","year":"2006","unstructured":"St-Pierre, J. et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397\u2013408 (2006).","journal-title":"Cell"},{"key":"1424_CR110","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","volume":"69","author":"G Mudo","year":"2012","unstructured":"Mudo, G. et al. Transgenic expression and activation of PGC-1alpha protect dopaminergic neurons in the MPTP mouse model of Parkinson\u2019s disease. Cell Mol. Life Sci. 69, 1153\u20131165 (2012).","journal-title":"Cell Mol. Life Sci."},{"key":"1424_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-12-69","volume":"12","author":"J Clark","year":"2011","unstructured":"Clark, J., Reddy, S., Zheng, K., Betensky, R. A. & Simon, D. K. Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson\u2019s disease. BMC Med. Genet. 12, 69 (2011).","journal-title":"BMC Med. Genet."},{"key":"1424_CR112","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/mds.27128","volume":"32","author":"B Brakedal","year":"2017","unstructured":"Brakedal, B. et al. Glitazone use associated with reduced risk of Parkinson\u2019s disease. Mov. Disord. 32, 1594\u20131599 (2017).","journal-title":"Mov. Disord."},{"key":"1424_CR113","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/jcp.21955","volume":"222","author":"K Tang","year":"2010","unstructured":"Tang, K., Wagner, P. D. & Breen, E. C. TNF-alpha-mediated reduction in PGC-1alpha may impair skeletal muscle function after cigarette smoke exposure. J. Cell Physiol. 222, 320\u2013327 (2010).","journal-title":"J. Cell Physiol."},{"key":"1424_CR114","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/1358863X221143152","volume":"28","author":"M Guo","year":"2023","unstructured":"Guo, M. et al. Cigarette smoking and mitochondrial dysfunction in peripheral artery disease. Vasc. Med. 28, 28\u201335 (2023).","journal-title":"Vasc. Med."},{"key":"1424_CR115","doi-asserted-by":"publisher","first-page":"8965","DOI":"10.1007\/s12035-018-1034-8","volume":"55","author":"JA Godoy","year":"2018","unstructured":"Godoy, J. A., Valdivieso, A. G. & Inestrosa, N. C. Nicotine modulates mitochondrial dynamics in hippocampal neurons. Mol. Neurobiol. 55, 8965\u20138977 (2018).","journal-title":"Mol. Neurobiol."},{"key":"1424_CR116","doi-asserted-by":"publisher","first-page":"L803","DOI":"10.1152\/ajplung.00158.2023","volume":"325","author":"NA Borkar","year":"2023","unstructured":"Borkar, N. A. et al. Nicotine affects mitochondrial structure and function in human airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 325, L803\u2013L818 (2023).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"1424_CR117","doi-asserted-by":"crossref","unstructured":"Investigators, N.E.T.i.P.D.F.-Z. Pioglitazone in early Parkinson\u2019s disease: a phase 2, multicentre, double-blind, randomised trial. Lancet Neurol. 14, 795\u2013803 (2015).","DOI":"10.1016\/S1474-4422(15)00144-1"},{"key":"1424_CR118","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.brainres.2016.10.029","volume":"1655","author":"Y Jang","year":"2017","unstructured":"Jang, Y. et al. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson\u2019s disease mice. Brain Res. 1655, 186\u2013193 (2017).","journal-title":"Brain Res."},{"key":"1424_CR119","doi-asserted-by":"publisher","first-page":"105519","DOI":"10.1016\/j.neuint.2023.105519","volume":"165","author":"YH Leem","year":"2023","unstructured":"Leem, Y. H., Park, J. S., Park, J. E., Kim, D. Y. & Kim, H. S. Suppression of neuroinflammation and alpha-synuclein oligomerization by rotarod walking exercise in subacute MPTP model of Parkinson\u2019s disease. Neurochem. Int. 165, 105519 (2023).","journal-title":"Neurochem. Int."},{"key":"1424_CR120","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1152\/japplphysiol.00164.2004","volume":"98","author":"AM Petersen","year":"2005","unstructured":"Petersen, A. M. & Pedersen, B. K. The anti-inflammatory effect of exercise. J. Appl. Physiol. (1985) 98, 1154\u20131162 (2005).","journal-title":"J. Appl. Physiol. (1985)"},{"key":"1424_CR121","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/261809","volume":"2015","author":"T Tuon","year":"2015","unstructured":"Tuon, T. et al. Physical training regulates mitochondrial parameters and neuroinflammatory mechanisms in an experimental model of Parkinson\u2019s disease. Oxid. Med. Cell Longev. 2015, 261809 (2015).","journal-title":"Oxid. Med. Cell Longev."},{"key":"1424_CR122","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13102-025-01279-z","volume":"17","author":"SM Tayebi","year":"2025","unstructured":"Tayebi, S. M., Poorhabibi, H., Heidary, D., Amini, M. A. & Sadeghi, A. Impact of aerobic exercise on chronic inflammation in older adults: a systematic review and meta-analysis. BMC Sports Sci. Med. Rehabil. 17, 229 (2025).","journal-title":"BMC Sports Sci. Med. Rehabil."},{"key":"1424_CR123","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/74680","volume":"6","author":"LE Otterbein","year":"2000","unstructured":"Otterbein, L. E. et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6, 422\u2013428 (2000).","journal-title":"Nat. Med."},{"key":"1424_CR124","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00264-011-1243-5","volume":"35","author":"Y Chen","year":"2011","unstructured":"Chen, Y., Guo, Q., Pan, X., Qin, L. & Zhang, P. Smoking and impaired bone healing: will activation of cholinergic anti-inflammatory pathway be the bridge? Int. Orthop. 35, 1267\u20131270 (2011).","journal-title":"Int. Orthop."},{"key":"1424_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-129","volume":"9","author":"SE Lakhan","year":"2011","unstructured":"Lakhan, S. E. & Kirchgessner, A. Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J. Transl. Med. 9, 129 (2011).","journal-title":"J. Transl. Med."},{"key":"1424_CR126","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/JPD-120157","volume":"3","author":"V Stuckenholz","year":"2013","unstructured":"Stuckenholz, V. et al. The alpha7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice. J. Parkinsons Dis. 3, 161\u2013172 (2013).","journal-title":"J. Parkinsons Dis."},{"key":"1424_CR127","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/jnr.23160","volume":"91","author":"S Suzuki","year":"2013","unstructured":"Suzuki, S. et al. 3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced Parkinsonian neurodegeneration through alpha7 nicotinic acetylcholine receptor stimulation in rats. J. Neurosci. Res. 91, 462\u2013471 (2013).","journal-title":"J. Neurosci. Res."},{"key":"1424_CR128","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00018-016-2175-4","volume":"73","author":"HO Kalkman","year":"2016","unstructured":"Kalkman, H. O. & Feuerbach, D. Modulatory effects of alpha7 nAChRs on the immune system and its relevance for CNS disorders. Cell Mol. Life Sci. 73, 2511\u20132530 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"1424_CR129","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.3748\/wjg.v12.i38.6098","volume":"12","author":"AR El-Zayadi","year":"2006","unstructured":"El-Zayadi, A. R. Heavy smoking and liver. World J. Gastroenterol. 12, 6098\u20136101 (2006).","journal-title":"World J. Gastroenterol."},{"key":"1424_CR130","doi-asserted-by":"publisher","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Y Arnson","year":"2010","unstructured":"Arnson, Y., Shoenfeld, Y. & Amital, H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J. Autoimmun. 34, J258\u2013265 (2010).","journal-title":"J. Autoimmun."},{"key":"1424_CR131","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-021-04183-x","volume":"600","author":"Z De Miguel","year":"2021","unstructured":"De Miguel, Z. et al. Exercise plasma boosts memory and dampens brain inflammation via clusterin. Nature 600, 494\u2013499 (2021).","journal-title":"Nature"},{"key":"1424_CR132","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1164\/rccm.200512-1835OC","volume":"174","author":"S Carnevali","year":"2006","unstructured":"Carnevali, S. et al. Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke. Am. J. Respir. Crit. Care Med. 174, 393\u2013399 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1424_CR133","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/ntr\/ntu151","volume":"17","author":"M Jamal","year":"2015","unstructured":"Jamal, M., Van der Does, W., Elzinga, B. M., Molendijk, M. L. & Penninx, B. W. Association between smoking, nicotine dependence, and BDNF Val66Met polymorphism with BDNF concentrations in serum. Nicotine Tob. Res. 17, 323\u2013329 (2015).","journal-title":"Nicotine Tob. Res."},{"key":"1424_CR134","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jad.2024.01.082","volume":"349","author":"A Shafiee","year":"2024","unstructured":"Shafiee, A. et al. Effect of smoking on brain-derived neurotrophic factor (BDNF) blood levels: a systematic review and meta-analysis. J. Affect Disord. 349, 525\u2013533 (2024).","journal-title":"J. Affect Disord."},{"key":"1424_CR135","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cmet.2013.09.008","volume":"18","author":"CD Wrann","year":"2013","unstructured":"Wrann, C. D. et al. Exercise induces hippocampal BDNF through a PGC-1alpha\/FNDC5 pathway. Cell Metab. 18, 649\u2013659 (2013).","journal-title":"Cell Metab."},{"key":"1424_CR136","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204835119","volume":"119","author":"TI Kam","year":"2022","unstructured":"Kam, T. I. et al. Amelioration of pathologic alpha-synuclein-induced Parkinson\u2019s disease by irisin. Proc. Natl. Acad. Sci. USA 119, e2204835119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1424_CR137","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.3933","volume":"5","author":"JYD Lu","year":"2017","unstructured":"Lu, J. Y. D. et al. The neuroprotective effect of nicotine in Parkinson\u2019s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage. PeerJ 5, e3933 (2017).","journal-title":"PeerJ"},{"key":"1424_CR138","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/j.1471-4159.2006.04078.x","volume":"98","author":"M Quik","year":"2006","unstructured":"Quik, M. et al. Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates. J. Neurochem. 98, 1866\u20131875 (2006).","journal-title":"J. Neurochem."},{"key":"1424_CR139","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/ene.13474","volume":"25","author":"G Villafane","year":"2018","unstructured":"Villafane, G. et al. High-dose transdermal nicotine in Parkinson\u2019s disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study. Eur. J. Neurol. 25, 120\u2013127 (2018).","journal-title":"Eur. J. Neurol."},{"key":"1424_CR140","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41531-024-00763-6","volume":"10","author":"KN Rose","year":"2024","unstructured":"Rose, K. N. et al. Neuroprotection of low dose carbon monoxide in Parkinson\u2019s disease models commensurate with the reduced risk of Parkinson\u2019s among smokers. NPJ Parkinsons Dis. 10, 152 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1424_CR141","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/STROKEAHA.110.607101","volume":"42","author":"B Wang","year":"2011","unstructured":"Wang, B., Cao, W., Biswal, S. & Dore, S. Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. Stroke 42, 2605\u20132610 (2011).","journal-title":"Stroke"},{"key":"1424_CR142","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1152\/japplphysiol.00469.2024","volume":"137","author":"T Urianstad","year":"2024","unstructured":"Urianstad, T. et al. Carbon monoxide supplementation: evaluating its potential to enhance altitude training effects and cycling performance in elite athletes. J. Appl. Physiol. (1985) 137, 1092\u20131105 (2024).","journal-title":"J. Appl. Physiol. (1985)"},{"key":"1424_CR143","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/mds.28544","volume":"36","author":"J Burtscher","year":"2021","unstructured":"Burtscher, J., Syed, M. M. K., Lashuel, H. A. & Millet, G. P. Hypoxia conditioning as a promising therapeutic target in Parkinson\u2019s disease? Mov. Disord. 36, 857\u2013861 (2021).","journal-title":"Mov. Disord."},{"key":"1424_CR144","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/ng.3067","volume":"46","author":"FR Lorenzo","year":"2014","unstructured":"Lorenzo, F. R. et al. A genetic mechanism for Tibetan high-altitude adaptation. Nat. Genet. 46, 951\u2013956 (2014).","journal-title":"Nat. Genet."},{"key":"1424_CR145","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1126\/science.aad9642","volume":"352","author":"IH Jain","year":"2016","unstructured":"Jain, I. H. et al. Hypoxia as a therapy for mitochondrial disease. Science 352, 54\u201361 (2016).","journal-title":"Science"},{"key":"1424_CR146","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cmet.2019.07.006","volume":"30","author":"IH Jain","year":"2019","unstructured":"Jain, I. H. et al. Leigh syndrome mouse model can be rescued by interventions that normalize brain hyperoxia, but not HIF activation. Cell Metab. 30, 824\u2013832 e823 (2019).","journal-title":"Cell Metab."},{"key":"1424_CR147","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1212\/WNL.0000000000001566","volume":"84","author":"RS Osorio","year":"2015","unstructured":"Osorio, R. S. et al. Sleep-disordered breathing advances cognitive decline in the elderly. Neurology 84, 1964\u20131971 (2015).","journal-title":"Neurology"},{"key":"1424_CR148","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamaneurol.2017.2180","volume":"74","author":"Y Leng","year":"2017","unstructured":"Leng, Y., McEvoy, C. T., Allen, I. E. & Yaffe, K. Association of sleep-disordered breathing with cognitive function and risk of cognitive impairment: a systematic review and meta-analysis. JAMA Neurol. 74, 1237\u20131245 (2017).","journal-title":"JAMA Neurol."},{"key":"1424_CR149","doi-asserted-by":"publisher","first-page":"e2293","DOI":"10.1097\/MD.0000000000002293","volume":"95","author":"NC Yeh","year":"2016","unstructured":"Yeh, N. C., Tien, K. J., Yang, C. M., Wang, J. J. & Weng, S. F. Increased risk of Parkinson\u2019s disease in patients with obstructive sleep apnea: a population-based, propensity score-matched, longitudinal follow-up study. Medicines (Baltimore) 95, e2293 (2016).","journal-title":"Medicines (Baltimore)"},{"key":"1424_CR150","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cell.2025.01.029","volume":"188","author":"SY Blume","year":"2025","unstructured":"Blume, S. Y. et al. HypoxyStat, a small-molecule form of hypoxia therapy that increases oxygen-hemoglobin affinity. Cell 188, 1580\u20131588 e1511 (2025).","journal-title":"Cell"},{"key":"1424_CR151","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/ars.2013.5593","volume":"21","author":"D Devos","year":"2014","unstructured":"Devos, D. et al. Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease. Antioxid. Redox Signal. 21, 195\u2013210 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"1424_CR152","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","volume":"387","author":"D Devos","year":"2022","unstructured":"Devos, D. et al. Trial of Deferiprone in Parkinson\u2019s Disease. N. Engl. J. Med. 387, 2045\u20132055 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1424_CR153","doi-asserted-by":"publisher","first-page":"9372182","DOI":"10.1155\/2019\/9372182","volume":"2019","author":"N Robledinos-Anton","year":"2019","unstructured":"Robledinos-Anton, N., Fernandez-Gines, R., Manda, G. & Cuadrado, A. Activators and inhibitors of NRF2: a review of their potential for clinical development. Oxid. Med Cell Longev. 2019, 9372182 (2019).","journal-title":"Oxid. Med Cell Longev."},{"key":"1424_CR154","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1124\/jpet.106.110866","volume":"321","author":"JM Han","year":"2007","unstructured":"Han, J. M. et al. Protective effect of sulforaphane against dopaminergic cell death. J. Pharm. Exp. Ther. 321, 249\u2013256 (2007).","journal-title":"J. Pharm. Exp. Ther."},{"key":"1424_CR155","first-page":"215","volume":"6","author":"C Deng","year":"2012","unstructured":"Deng, C., Tao, R., Yu, S. Z. & Jin, H. Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by sulforaphane through the activation of Nrf2 nuclear translocation. Mol. Med. Rep. 6, 215\u2013219 (2012).","journal-title":"Mol. Med. Rep."},{"key":"1424_CR156","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/jnr.21975","volume":"87","author":"A Siebert","year":"2009","unstructured":"Siebert, A., Desai, V., Chandrasekaran, K., Fiskum, G. & Jafri, M. S. Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures. J. Neurosci. Res. 87, 1659\u20131669 (2009).","journal-title":"J. Neurosci. Res."},{"key":"1424_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148462","volume":"1815","author":"M Khot","year":"2023","unstructured":"Khot, M. et al. Dimethyl fumarate ameliorates Parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2\/Cathepsin D axis. Brain Res. 1815, 148462 (2023).","journal-title":"Brain Res."},{"key":"1424_CR158","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2015.6549","volume":"25","author":"I Lastres-Becker","year":"2016","unstructured":"Lastres-Becker, I. et al. Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson\u2019s disease. Antioxid. Redox Signal 25, 61\u201377 (2016).","journal-title":"Antioxid. Redox Signal"},{"key":"1424_CR159","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1523\/JNEUROSCI.0426-16.2016","volume":"36","author":"M Ahuja","year":"2016","unstructured":"Ahuja, M. et al. Distinct Nrf2 signaling mechanisms of fumaric acid esters and their role in neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-tetrahydropyridine-induced experimental Parkinson\u2019s-like disease. J. Neurosci. 36, 6332\u20136351 (2016).","journal-title":"J. Neurosci."},{"key":"1424_CR160","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuroscience.2014.11.047","volume":"286","author":"X Jing","year":"2015","unstructured":"Jing, X. et al. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson\u2019s disease by enhancing Nrf2 activity. Neuroscience 286, 131\u2013140 (2015).","journal-title":"Neuroscience"},{"key":"1424_CR161","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.29286","volume":"38","author":"DR Lynch","year":"2023","unstructured":"Lynch, D. R. et al. Efficacy of omaveloxolone in Friedreich\u2019s ataxia: delayed-start analysis of the MOXIe extension. Mov. Disord. 38, 313\u2013320 (2023).","journal-title":"Mov. Disord."},{"key":"1424_CR162","doi-asserted-by":"publisher","first-page":"e687","DOI":"10.1212\/WNL.0000000000008861","volume":"94","author":"KL Madsen","year":"2020","unstructured":"Madsen, K. L. et al. Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trial. Neurology 94, e687\u2013e698 (2020).","journal-title":"Neurology"},{"key":"1424_CR163","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12311-023-01568-8","volume":"23","author":"SH Subramony","year":"2024","unstructured":"Subramony, S. H. & Lynch, D. L. A milestone in the treatment of ataxias: approval of omaveloxolone for Friedreich ataxia. Cerebellum 23, 775\u2013777 (2024).","journal-title":"Cerebellum"},{"key":"1424_CR164","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molmet.2018.01.017","volume":"9","author":"AT Pettersson-Klein","year":"2018","unstructured":"Pettersson-Klein, A. T. et al. Small molecule PGC-1alpha1 protein stabilizers induce adipocyte Ucp1 expression and uncoupled mitochondrial respiration. Mol. Metab. 9, 28\u201342 (2018).","journal-title":"Mol. Metab."},{"key":"1424_CR165","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2337\/db12-0703","volume":"62","author":"LN Zhang","year":"2013","unstructured":"Zhang, L. N. et al. Novel small-molecule PGC-1alpha transcriptional regulator with beneficial effects on diabetic db\/db mice. Diabetes 62, 1297\u20131307 (2013).","journal-title":"Diabetes"},{"key":"1424_CR166","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41420-025-02651-1","volume":"11","author":"X Zhang","year":"2025","unstructured":"Zhang, X. et al. Mitochondrial dysfunction-mediated metabolic remodeling of TCA cycle promotes Parkinson\u2019s disease through inhibition of H3K4me3 demethylation. Cell Death Discov. 11, 351 (2025).","journal-title":"Cell Death Discov."},{"key":"1424_CR167","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12035-025-05612-y","volume":"63","author":"J Kaur","year":"2025","unstructured":"Kaur, J. & Naqvi, S. ZLN005 alleviates the dopaminergic degeneration via PGC-1alpha-mediated mitochondrial homeostasis in Parkinson\u2019s disease. Mol. Neurobiol. 63, 303 (2025).","journal-title":"Mol. Neurobiol."},{"key":"1424_CR168","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JPD-191900","volume":"10","author":"JLY Cheong","year":"2020","unstructured":"Cheong, J. L. Y., de Pablo-Fernandez, E., Foltynie, T. & Noyce, A. J. The Association between type 2 diabetes mellitus and Parkinson\u2019s disease. J. Parkinsons Dis. 10, 775\u2013789 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"1424_CR169","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/mds.27360","volume":"33","author":"AE Lang","year":"2018","unstructured":"Lang, A. E. & Espay, A. J. Disease modification in Parkinson\u2019s Disease: current approaches, challenges, and future considerations. Mov. Disord. 33, 660\u2013677 (2018).","journal-title":"Mov. Disord."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01424-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01424-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01424-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:02:49Z","timestamp":1781010169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01424-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":169,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01424-6","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}